Consensus $331.23M. Raises FY24 adjusted EBITDA view to (2M)-$4M from (6M)-(1M). Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on SKIN: SKIN Earnings Report this Week: Is It a Buy, Ahead of Earnings? Beauty Health Announces Chief Revenue Officer Departure Beauty Health appoints Chief Revenue Officer and Chief Marketing Officer
